Salient Private Client’s ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B MLPZ Stock Holding History

Salient Private Client’s Portfolio MLPZ Stock Details MLPZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$484K	Buy	11,529 +127	+1%	+$5.4K	0.09%	95
2018 Q2	$444K	Buy	11,402 +468	+4%	+$17.2K	0.07%	115
2018 Q1	$356K	Buy	10,934 +317	+3%	+$13.5K	0.06%	121
2017 Q4	$455K	Buy	+10,617	New	+$432K	0.09%	91

Other funds holding MLPZ

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Salient Private Client's MLPZ Position: Q3 2018 in Review

Salient Private Client increased its ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) stake by 1.1% in Q3 2018, buying an estimated $5.4K and bringing the position to 11,529 shares worth $484K. The position accounts for 0.09% of the portfolio, ranked #95.

Salient Private Client first reported a position in MLPZ in Q4 2017 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold MLPZ as of Q3 2018.

Salient Private Client held 11,529 shares of ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B worth $484K as of Q3 2018.
Salient Private Client bought 127 ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B shares in Q3 2018, an estimated $5.4K.
ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B made up 0.09% of Salient Private Client's portfolio in Q3 2018, its #95 holding.
Salient Private Client first reported a position in ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B in Q4 2017 and has held it in 4 quarters since.
2 funds tracked by Wall St. Rank held ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B as of Q3 2018.

Based on Salient Private Client's 13F filing for Q3 2018, filed 14 Nov 2018.